Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Bennett

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Nature Communications|January 16, 2014
Integrin CD11b positively regulates TLR4-induced signalling pathways in dendritic cells but not in macrophagesGuang Sheng Ling, Jason Bennett, Kevin J Woollard, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Curation at Scale with EPITOME: Extraction Pipeline for Immunological Texts and Open-Source Multimodal EnquiryEve Richardson, Parker Lischwe, Jason Bennett, et al.
Urology|May 2, 2016
Three-year Follow-up Results of a Prospective, Multicenter Study in Overactive Bladder Subjects Treated With Sacral NeuromodulationSteven Siegel, Karen Noblett, Jeffrey Mangel, et al.
International Journal of Molecular Sciences|February 15, 2022
Metabolites of Cannabis Induce Cardiac Toxicity and Morphological Alterations in Cardiac MyocytesAyse Orme Merve, Pola Sobiecka, Vytautas Remeškevičius, et al.
Neurourology and Urodynamics|December 30, 2014
Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladderKaren Noblett, Steven Siegel, Jeffrey Mangel, et al.
The Journal of Urology|July 16, 2017
Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral NeuromodulationSteven Siegel, Karen Noblett, Jeffrey Mangel, et al.
Neurourology and Urodynamics|January 14, 2014
Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladderSteven Siegel, Karen Noblett, Jeffrey Mangel, et al.
Malaria Journal|June 21, 2013
The metabolism of primaquine to its active metabolite is dependent on CYP 2D6Brandon S Pybus, Sean R Marcsisin, Xiannu Jin, et al.
Nucleic Acids Research|November 18, 2024
The Immune Epitope Database (IEDB): 2024 updateRandi Vita, Nina Blazeska, Daniel Marrama, et al.
Emerging Infectious Diseases|November 12, 2024
Molecular Surveillance of Multidrug-Resistant Bacteria among Refugees from Afghanistan in 2 US Military Hospitals during Operation Allies Refuge, 2021Cole Anderson, Francois Lebreton, Emma Mills, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Nature Communications|January 16, 2014
Integrin CD11b positively regulates TLR4-induced signalling pathways in dendritic cells but not in macrophagesGuang Sheng Ling, Jason Bennett, Kevin J Woollard, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Curation at Scale with EPITOME: Extraction Pipeline for Immunological Texts and Open-Source Multimodal EnquiryEve Richardson, Parker Lischwe, Jason Bennett, et al.
Urology|May 2, 2016
Three-year Follow-up Results of a Prospective, Multicenter Study in Overactive Bladder Subjects Treated With Sacral NeuromodulationSteven Siegel, Karen Noblett, Jeffrey Mangel, et al.
International Journal of Molecular Sciences|February 15, 2022
Metabolites of Cannabis Induce Cardiac Toxicity and Morphological Alterations in Cardiac MyocytesAyse Orme Merve, Pola Sobiecka, Vytautas Remeškevičius, et al.
Neurourology and Urodynamics|December 30, 2014
Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladderKaren Noblett, Steven Siegel, Jeffrey Mangel, et al.
The Journal of Urology|July 16, 2017
Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral NeuromodulationSteven Siegel, Karen Noblett, Jeffrey Mangel, et al.
Neurourology and Urodynamics|January 14, 2014
Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladderSteven Siegel, Karen Noblett, Jeffrey Mangel, et al.
Malaria Journal|June 21, 2013
The metabolism of primaquine to its active metabolite is dependent on CYP 2D6Brandon S Pybus, Sean R Marcsisin, Xiannu Jin, et al.
Nucleic Acids Research|November 18, 2024
The Immune Epitope Database (IEDB): 2024 updateRandi Vita, Nina Blazeska, Daniel Marrama, et al.
Emerging Infectious Diseases|November 12, 2024
Molecular Surveillance of Multidrug-Resistant Bacteria among Refugees from Afghanistan in 2 US Military Hospitals during Operation Allies Refuge, 2021Cole Anderson, Francois Lebreton, Emma Mills, et al.
Pageof 6